GRN and neoplasm: Moreover, studies exploring dynamic fluctuations in GRN levels during treatment and its interaction with immune checkpoint pathways and T-cell infiltration are needed to deepen our understanding of GRN’s role in shaping tumor immunogenicity and therapeutic resistance.